Developer docs
API playgroundTry for free, no card

Search company profiles

ConnectiveRx

Full company profile

uuid0004tad

Namestring
ConnectiveRx
Legal namestring
PSKW, LLC
Company typeenum
Private
Founded yearint
2009
Descriptiontext

ConnectiveRx (legal entity PSKW, LLC) is a privately held US healthcare technology company that delivers technology-enabled patient support, affordability, and adherence solutions for pharmaceutical manufacturers, healthcare providers, and patients on specialty and branded medications. Its platform bundles hub services (benefits verification, prior authorization, patient enrollment, case management), end-to-end patient affordability programs, point-of-care EHR messaging, and a proprietary Enterprise Data Platform (EDP) that aggregates patient-level data across hub, copay, and pharmacy services into a single patient-journey view. Recent product extensions include ConnectiveRx Pharmacy, a fully-licensed dispensing pharmacy launched in September 2025 for direct-to-patient specialty medication distribution, and ShieldRx, an AI-driven pharmacy monitoring and misuse-prevention engine co-developed with EagleForce and launched in April 2026. The company operates the largest clinically embedded prescriber network cited in its marketing, reaching 1.2 million prescribers across 750,000+ EHR systems and 84 million+ patients annually.

The business model is built on enterprise contracts with pharmaceutical manufacturers, primarily through subscription or recurring service fees for hub services and EHR messaging campaigns, transaction-based fees from pharmacy dispensing, and revenue-protection contracts for ShieldRx. Go-to-market runs through enterprise field sales and inside sales teams targeting pharma commercialization leads, an RFP submission process, and thought leadership at industry conferences (Asembia, Hub East, PAP, POC Now, HIMSS, MM+M Transform). Named and awarded customers include Biogen, AstraZeneca, and Teva. ConnectiveRx maintains dual headquarters in Whippany, NJ and Pittsburgh, PA, with operations support in Fairfield, and operates as a privately held company backed by Genstar Capital, Harvest Partners Structured Capital, and Blackstone Tactical Opportunities following a March 2020 funding round.

Short descriptiontext

ConnectiveRx is a US healthcare technology company providing technology-enabled hub services, patient affordability programs, point-of-care EHR messaging, and specialty pharmacy distribution for pharmaceutical manufacturers, healthcare providers, and patients across 84 million+ patient journeys annually.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersWhippany, United States
HQ citystring
Whippany
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical hub services, patient affordability programs, EHR messaging solutions, specialty medication support, pharmacy benefits management
Industry5 codes
PRIMARYHLAIAKAG
Patient Access Programs & Affordability (Copay/Hubs/PSP)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAF
Medication Adherence, Reminders & Patient Support
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAN
Medication Pricing, Copay Assistance & Patient Financial Support Tools
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLAEAKAL
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
NAICS code2 codes
  • All Other Outpatient Care Centers621498
  • Social Assistance624
SIC code1 code
  • Services-Health Services8000
Product category
Pharmaceutical Patient Access & Hub Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Hub Services for Pharma Manufacturers
TypeSubscription Recurring
Description

ConnectiveRx provides technology-enabled hub services to pharmaceutical manufacturers for specialty and branded medications, including benefits verification, prior authorization support, patient enrollment, and adherence programs. Revenue is derived from service fees charged to pharma manufacturer clients, typically under contractual arrangements tied to program scope and patient volume.

connectiverx.com
2Point-of-Care EHR Messaging
TypeSubscription Recurring
Description

In-workflow EHR messaging services delivered to healthcare providers, generating revenue through brand programs sponsored by pharmaceutical manufacturer clients. Pricing is based on provider reach, message volume, and therapeutic area coverage.

connectiverx.com
3Pharmacy Dispensing Services
TypeTransaction Fee
Description

Direct-to-patient specialty medication distribution through ConnectiveRx Pharmacy, a fully-licensed dispensing pharmacy. Revenue generated from pharmaceutical manufacturers as part of integrated patient support and distribution solutions.

finance.yahoo.com
4ShieldRx (Pharmacy Monitoring)
TypeSubscription Recurring
Description

AI-driven pharmacy monitoring and misuse prevention solution targeting revenue protection for pharmaceutical manufacturers. Revenue is derived from service contracts with pharma brands, based on detection performance and claim volume monitored.

businesswire.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1ConnectiveRx Pharmacy
Description

A tech-driven, fully-licensed dispensing pharmacy for direct-to-patient specialty medication distribution.

connectiverx.com
+3 more records
Core offering1 text field

ConnectiveRx delivers technology-enabled patient support and access solutions for pharmaceutical manufacturers, including hub services (benefits verification, prior authorization, patient enrollment, copay assistance, and adherence messaging), point-of-care EHR messaging campaigns reaching 1.2M+ prescribers, direct-to-patient specialty medication dispensing through ConnectiveRx Pharmacy, AI-driven pharmacy misuse monitoring (ShieldRx), and the Enterprise Data Platform unifying the patient journey across services. The company operates as a single-partner solution designed to help patients get on and stay on therapy while protecting manufacturer revenue.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 13-15% higher first-fill rates and stronger patient adherence across key therapeutic areas (cardiovascular, diabetes, women's health)
+5 more records
Product and service9 records
1Hub Services and Patient Support
CategoryHub Services / Patient Support
Description

End-to-end patient support services for pharmaceutical manufacturers including benefits verification, prior authorization support, patient enrollment, case management, copay assistance, and adherence messaging for patients prescribed specialty and branded medications.

2Point-of-Care EHR Messaging
CategoryPoint-of-Care Messaging / Prescriber Engagement
Description

In-workflow messaging campaigns delivered to healthcare providers (physicians, nurse practitioners, physician assistants) directly within electronic health records, supporting prescription savings offers, clinical communications, formulary pull-through, and patient adherence reminders across cardiovascular, diabetes, women's health, and other therapeutic areas.

3ConnectiveRx Pharmacy
CategorySpecialty Pharmacy / Dispensing
Description

Fully-licensed dispensing pharmacy providing integrated direct-to-patient specialty medication distribution for pharmaceutical manufacturers, managing intake, fulfillment, and the complete patient access process alongside ConnectiveRx's hub services.

4ShieldRx
CategoryAI-driven Pharmacy Monitoring / Revenue Protection
Description

AI-driven pharmacy monitoring and misuse-prevention engine that evaluates pharmacy claims in real time using AI risk scoring and a pharmacist resolution center, protecting pharmaceutical manufacturer revenue from pharmacy fraud, misuse, and invalid copay behavior. Addresses an estimated $5B in annual manufacturer revenue loss.

5Enterprise Data Platform (EDP)
CategoryData & Analytics Platform
Description

Enterprise data warehouse and visual intelligence platform that unifies patient-level data from hub services, copay programs, and pharmacy claims into a single real-time view of the patient journey, enabling pharma brands and field reimbursement managers to access dashboards and predictive insights.

6Electronic Benefit Verification (eBV) and Electronic Prior Authorization (ePA)
CategoryPatient Access / Benefits Verification
Description

Electronic services that automate benefits verification and prior authorization, providing real-time coverage insights to healthcare providers and accelerating patient onboarding onto specialty and branded therapies.

7Non-Commercial Pharmacy
CategoryPatient Enrollment / Pharmacy Channel
Description

A non-commercial pharmacy channel that expands patient enrollment opportunities by connecting patients at the pharmacy level, capturing those who might otherwise fall through traditional enrollment gaps in hub programs.

8ScriptGuide
CategoryAdherence / In-Workflow Messaging
Description

In-workflow EHR messaging program focused on persistence and adherence, designed to improve new-prescription fill rates and ongoing medication adherence across multiple therapeutic areas.

9Rx Savings Assistant® (EHR-integrated prescription savings)
CategoryEHR-integrated Savings / Affordability
Description

Prescription savings software facilitating prescription savings offers directly within electronic health records, integrated into ConnectiveRx's EHR Network to support healthcare providers and patients across the US.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-08
Description

ConnectiveRx and EagleForce jointly developed and launched ShieldRx, an AI-driven pharmacy monitoring and misuse prevention engine. EagleForce contributed real-time identity and transaction intelligence capabilities, while ConnectiveRx provided pharmacy workflow integration and adjudication expertise. The partnership combines AI-driven risk models with EagleForce's transaction intelligence to flag suspicious pharmacy activity before claims are paid, addressing $5 billion in annual manufacturer revenue loss.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-12-09
Description

ConnectiveRx acquired Rx Savings Assistant® from Medicom Digital, integrating it into its EHR Network which connects healthcare providers and patients across the US. The software facilitates prescription savings offers directly within electronic health records.

Strategic tierCoreTypeTechnology or Integration
Description

ConnectiveRx has de-carbonized its operations by partnering with AWS for all cloud computing solutions. AWS provides the cloud infrastructure supporting ConnectiveRx's SaaS platform for hub services, EHR integrations, pharmacy monitoring, and data analytics.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

ConnectiveRx joined POCMA as a member, with President and Chief Commercial Officer Frank Dana joining POCMA's board of directors. The partnership provides ConnectiveRx a platform to enhance education, thought-leadership, and solutions that advance the point-of-care industry and support patients along their health journey.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1TrialCard
TypeDirect peer
Description

Pharma-focused hub services and patient access solutions provider offering copay programs, affordability, adherence, and patient support services to branded and specialty manufacturers—directly overlapping with ConnectiveRx's hub and affordability offerings.

TypeDirect peer
Description

Digital health company delivering in-workflow EHR messaging to HCPs for pharma manufacturers, including financial assistance, clinical messaging, and adherence support—directly comparable to ConnectiveRx's Point-of-Care EHR Network.

TypeDirect peer
Description

Specialty therapy patient access and hub services provider offering eBV, ePA, patient enrollment, and adherence for pharma manufacturers—closely overlapping with ConnectiveRx's hub services platform.

4CoverMyMeds (McKesson)
TypeDirect peer
Description

McKesson-owned ePA, benefit verification, and patient access platform serving providers, pharmacists, and pharma manufacturers—directly competing in ePA/eBV and integrated hub workflows that ConnectiveRx also delivers.

TypeDirect peer
Description

Point-of-care health information network reaching providers and patients in-office and via digital channels, including EHR-integrated messaging for pharma brands—closely comparable to ConnectiveRx's point-of-care messaging offering.

TypeDirect peer
Description

Point-of-care health education and messaging platform delivering content and brand programs through HCP office networks and digital channels—competing with ConnectiveRx for pharma point-of-care messaging budgets.

TypeDirect peer
Description

Pharma services provider offering patient access, hub, adherence, and affordability programs for manufacturers as part of Express Scripts' broader services portfolio—directly overlapping with ConnectiveRx's hub and patient support offerings.

TypeBroad incumbent
Description

Global CRO and commercial solutions provider with patient access, hub, and real-world evidence capabilities serving pharma manufacturers—offers overlapping capabilities to ConnectiveRx as part of a much broader services portfolio.

9McKesson
TypeBroad incumbent
Description

Diversified pharmaceutical distributor and healthcare services giant owning CoverMyMeds, US Oncology, and specialty pharmacy capabilities—competes with ConnectiveRx across hub, specialty pharmacy, and ePA, but as part of a much broader enterprise.

TypeOthers
Description

Health information network operating e-prescribing, benefit, and clinical interoperability infrastructure used by EHRs, pharmacies, and PBMs—an enabling/adjacent platform whose e-prescribing and real-time benefit tools are complementary and partially competitive with ConnectiveRx's eBV/ePA workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles21 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ConnectiveRx

Pharmaceutical Patient Access & Hub Servicesconnectiverx.com

ConnectiveRx is a US healthcare technology company providing technology-enabled hub services, patient affordability programs, point-of-care EHR messaging, and specialty pharmacy distribution for pharmaceutical manufacturers, healthcare providers, and patients across 84 million+ patient journeys annually.

What ConnectiveRx does

ConnectiveRx (legal entity PSKW, LLC) is a privately held US healthcare technology company that delivers technology-enabled patient support, affordability, and adherence solutions for pharmaceutical manufacturers, healthcare providers, and patients on specialty and branded medications. Its platform bundles hub services (benefits verification, prior authorization, patient enrollment, case management), end-to-end patient affordability programs, point-of-care EHR messaging, and a proprietary Enterprise Data Platform (EDP) that aggregates patient-level data across hub, copay, and pharmacy services into a single patient-journey view. Recent product extensions include ConnectiveRx Pharmacy, a fully-licensed dispensing pharmacy launched in September 2025 for direct-to-patient specialty medication distribution, and ShieldRx, an AI-driven pharmacy monitoring and misuse-prevention engine co-developed with EagleForce and launched in April 2026. The company operates the largest clinically embedded prescriber network cited in its marketing, reaching 1.2 million prescribers across 750,000+ EHR systems and 84 million+ patients annually.

The business model is built on enterprise contracts with pharmaceutical manufacturers, primarily through subscription or recurring service fees for hub services and EHR messaging campaigns, transaction-based fees from pharmacy dispensing, and revenue-protection contracts for ShieldRx. Go-to-market runs through enterprise field sales and inside sales teams targeting pharma commercialization leads, an RFP submission process, and thought leadership at industry conferences (Asembia, Hub East, PAP, POC Now, HIMSS, MM+M Transform). Named and awarded customers include Biogen, AstraZeneca, and Teva. ConnectiveRx maintains dual headquarters in Whippany, NJ and Pittsburgh, PA, with operations support in Fairfield, and operates as a privately held company backed by Genstar Capital, Harvest Partners Structured Capital, and Blackstone Tactical Opportunities following a March 2020 funding round.

ConnectiveRx firmographics

Firmographics
Name
ConnectiveRx
Legal name
PSKW, LLC
Website
https://connectiverx.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
ConnectiveRx is a US healthcare technology company providing technology-enabled hub services, patient affordability programs, point-of-care EHR messaging, and specialty pharmacy distribution for pharmaceutical manufacturers, healthcare providers, and patients across 84 million+ patient journeys annually.
Ownership category
akta.pro rank

ConnectiveRx industry classification

Industry
Product category
Pharmaceutical Patient Access & Hub Services
NAICS
All Other Outpatient Care Centers (621498), Social Assistance (624)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAIAKAG
Patient Access Programs & Affordability (Copay/Hubs/PSP)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAF
Medication Adherence, Reminders & Patient Support
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAN
Medication Pricing, Copay Assistance & Patient Financial Support Tools
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLAEAKAL
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)

Keywords

  • Pharmaceutical hub services
  • Patient affordability programs
  • EHR messaging solutions
  • Specialty medication support
  • Pharmacy benefits management

Where ConnectiveRx is headquartered

Location

Headquarters

HQ city
Whippany
HQ country
United States
HQ region
North America

Offices3 records

Markets served

ConnectiveRx business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Hub Services for Pharma Manufacturers: ConnectiveRx provides technology-enabled hub services to pharmaceutical manufacturers for specialty and branded medications, including benefits verification, prior authorization support, patient enrollment, and adherence programs. Revenue is derived from service fees charged to pharma manufacturer clients, typically under contractual arrangements tied to program scope and patient volume.
  2. Point-of-Care EHR Messaging: In-workflow EHR messaging services delivered to healthcare providers, generating revenue through brand programs sponsored by pharmaceutical manufacturer clients. Pricing is based on provider reach, message volume, and therapeutic area coverage.
  3. Pharmacy Dispensing Services: Direct-to-patient specialty medication distribution through ConnectiveRx Pharmacy, a fully-licensed dispensing pharmacy. Revenue generated from pharmaceutical manufacturers as part of integrated patient support and distribution solutions.
  4. ShieldRx (Pharmacy Monitoring): AI-driven pharmacy monitoring and misuse prevention solution targeting revenue protection for pharmaceutical manufacturers. Revenue is derived from service contracts with pharma brands, based on detection performance and claim volume monitored.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

ConnectiveRx product offering

Product offering

Core offering

ConnectiveRx delivers technology-enabled patient support and access solutions for pharmaceutical manufacturers, including hub services (benefits verification, prior authorization, patient enrollment, copay assistance, and adherence messaging), point-of-care EHR messaging campaigns reaching 1.2M+ prescribers, direct-to-patient specialty medication dispensing through ConnectiveRx Pharmacy, AI-driven pharmacy misuse monitoring (ShieldRx), and the Enterprise Data Platform unifying the patient journey across services. The company operates as a single-partner solution designed to help patients get on and stay on therapy while protecting manufacturer revenue.

Differentiator

Problem solved

Functional benefit

Brands

  • ConnectiveRx Pharmacy: A tech-driven, fully-licensed dispensing pharmacy for direct-to-patient specialty medication distribution.
  • ShieldRx
  • EHR Network
  • Enterprise Data Platform (EDP)

Products and services

  • Hub Services and Patient Support End-to-end patient support services for pharmaceutical manufacturers including benefits verification, prior authorization support, patient enrollment, case management, copay assistance, and adherence messaging for patients prescribed specialty and branded medications.
  • Point-of-Care EHR Messaging In-workflow messaging campaigns delivered to healthcare providers (physicians, nurse practitioners, physician assistants) directly within electronic health records, supporting prescription savings offers, clinical communications, formulary pull-through, and patient adherence reminders across cardiovascular, diabetes, women's health, and other therapeutic areas.
  • ConnectiveRx Pharmacy Fully-licensed dispensing pharmacy providing integrated direct-to-patient specialty medication distribution for pharmaceutical manufacturers, managing intake, fulfillment, and the complete patient access process alongside ConnectiveRx's hub services.
  • ShieldRx AI-driven pharmacy monitoring and misuse-prevention engine that evaluates pharmacy claims in real time using AI risk scoring and a pharmacist resolution center, protecting pharmaceutical manufacturer revenue from pharmacy fraud, misuse, and invalid copay behavior. Addresses an estimated $5B in annual manufacturer revenue loss.
  • Enterprise Data Platform (EDP) Enterprise data warehouse and visual intelligence platform that unifies patient-level data from hub services, copay programs, and pharmacy claims into a single real-time view of the patient journey, enabling pharma brands and field reimbursement managers to access dashboards and predictive insights.
  • Electronic Benefit Verification (eBV) and Electronic Prior Authorization (ePA) Electronic services that automate benefits verification and prior authorization, providing real-time coverage insights to healthcare providers and accelerating patient onboarding onto specialty and branded therapies.
  • Non-Commercial Pharmacy A non-commercial pharmacy channel that expands patient enrollment opportunities by connecting patients at the pharmacy level, capturing those who might otherwise fall through traditional enrollment gaps in hub programs.
  • ScriptGuide In-workflow EHR messaging program focused on persistence and adherence, designed to improve new-prescription fill rates and ongoing medication adherence across multiple therapeutic areas.
  • Rx Savings Assistant® (EHR-integrated prescription savings) Prescription savings software facilitating prescription savings offers directly within electronic health records, integrated into ConnectiveRx's EHR Network to support healthcare providers and patients across the US.

Quantifiable outcome

  • 13-15% higher first-fill rates and stronger patient adherence across key therapeutic areas (cardiovascular, diabetes, women's health)
  • +5 more outcomes

Companies that use ConnectiveRx

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles1 record

ConnectiveRx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

ConnectiveRx partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • EagleForcecoreStrategic or Co-development Partner · 8 April 2026ConnectiveRx and EagleForce jointly developed and launched ShieldRx, an AI-driven pharmacy monitoring and misuse prevention engine. EagleForce contributed real-time identity and transaction intelligence capabilities, while ConnectiveRx provided pharmacy workflow integration and adjudication expertise. The partnership combines AI-driven risk models with EagleForce's transaction intelligence to flag suspicious pharmacy activity before claims are paid, addressing $5 billion in annual manufacturer revenue loss.
  • Medicom DigitalcoreTechnology or Integration · 9 December 2021ConnectiveRx acquired Rx Savings Assistant® from Medicom Digital, integrating it into its EHR Network which connects healthcare providers and patients across the US. The software facilitates prescription savings offers directly within electronic health records.
  • Amazon Web Services (AWS)coreTechnology or IntegrationConnectiveRx has de-carbonized its operations by partnering with AWS for all cloud computing solutions. AWS provides the cloud infrastructure supporting ConnectiveRx's SaaS platform for hub services, EHR integrations, pharmacy monitoring, and data analytics.
  • Point of Care Marketing Association (POCMA)minorStrategic or Co-development PartnerConnectiveRx joined POCMA as a member, with President and Chief Commercial Officer Frank Dana joining POCMA's board of directors. The partnership provides ConnectiveRx a platform to enhance education, thought-leadership, and solutions that advance the point-of-care industry and support patients along their health journey.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

ConnectiveRx competitors and assessment

Company assessment

Direct peers

  • TrialCard: Pharma-focused hub services and patient access solutions provider offering copay programs, affordability, adherence, and patient support services to branded and specialty manufacturers—directly overlapping with ConnectiveRx's hub and affordability offerings.
  • OptimizeRx: Digital health company delivering in-workflow EHR messaging to HCPs for pharma manufacturers, including financial assistance, clinical messaging, and adherence support—directly comparable to ConnectiveRx's Point-of-Care EHR Network.
  • AssistRx: Specialty therapy patient access and hub services provider offering eBV, ePA, patient enrollment, and adherence for pharma manufacturers—closely overlapping with ConnectiveRx's hub services platform.
  • CoverMyMeds (McKesson): McKesson-owned ePA, benefit verification, and patient access platform serving providers, pharmacists, and pharma manufacturers—directly competing in ePA/eBV and integrated hub workflows that ConnectiveRx also delivers.
  • PatientPoint: Point-of-care health information network reaching providers and patients in-office and via digital channels, including EHR-integrated messaging for pharma brands—closely comparable to ConnectiveRx's point-of-care messaging offering.
  • Outcome Health: Point-of-care health education and messaging platform delivering content and brand programs through HCP office networks and digital channels—competing with ConnectiveRx for pharma point-of-care messaging budgets.
  • UBC (United BioSource): Pharma services provider offering patient access, hub, adherence, and affordability programs for manufacturers as part of Express Scripts' broader services portfolio—directly overlapping with ConnectiveRx's hub and patient support offerings.

Broad incumbents

  • IQVIA: Global CRO and commercial solutions provider with patient access, hub, and real-world evidence capabilities serving pharma manufacturers—offers overlapping capabilities to ConnectiveRx as part of a much broader services portfolio.
  • McKesson: Diversified pharmaceutical distributor and healthcare services giant owning CoverMyMeds, US Oncology, and specialty pharmacy capabilities—competes with ConnectiveRx across hub, specialty pharmacy, and ePA, but as part of a much broader enterprise.

Others

  • Surescripts: Health information network operating e-prescribing, benefit, and clinical interoperability infrastructure used by EHRs, pharmacies, and PBMs—an enabling/adjacent platform whose e-prescribing and real-time benefit tools are complementary and partially competitive with ConnectiveRx's eBV/ePA workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

ConnectiveRx social profiles

Digital presence

ConnectiveRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ConnectiveRx leadership team

Management profile

Number of profiles

Profiles21 records

ConnectiveRx funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ConnectiveRx M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ConnectiveRx

What does ConnectiveRx do?

ConnectiveRx delivers technology-enabled patient support and access solutions for pharmaceutical manufacturers, including hub services (benefits verification, prior authorization, patient enrollment, copay assistance, and adherence messaging), point-of-care EHR messaging campaigns reaching 1.2M+ prescribers, direct-to-patient specialty medication dispensing through ConnectiveRx Pharmacy, AI-driven pharmacy misuse monitoring (ShieldRx), and the Enterprise Data Platform unifying the patient journey across services. The company operates as a single-partner solution designed to help patients get on and stay on therapy while protecting manufacturer revenue.

Is ConnectiveRx a public or private company?

ConnectiveRx is a private company. It is classified as private equity controlled and is currently operating.

When was ConnectiveRx founded?

ConnectiveRx was founded in 2009. It employs 1,001 to 5,000 people.

Where is ConnectiveRx based?

ConnectiveRx is headquartered in Whippany, United States, in the North America region.

How does ConnectiveRx make money?

Four revenue lines are on record. Hub Services for Pharma Manufacturers are the primary driver. The others are point-of-Care EHR Messaging, pharmacy Dispensing Services and shieldRx (Pharmacy Monitoring).

Who are ConnectiveRx's main competitors?

Direct peers on record are TrialCard, OptimizeRx, AssistRx, CoverMyMeds (McKesson), PatientPoint, Outcome Health and UBC (United BioSource). Broad incumbents are IQVIA and McKesson. Surescripts is listed as an others.

Does ConnectiveRx have an API?

No public API is recorded for ConnectiveRx.

What industry is ConnectiveRx in?

ConnectiveRx's product category is Pharmaceutical Patient Access & Hub Services. Its primary akta.pro industry code is HLAIAKAG, Patient Access Programs & Affordability (Copay/Hubs/PSP), with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 621498 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageConnectiveRx Earns Top Rankings From McKinsey, Named MM+M Power Partner; Three Leaders Named to PM360 ELITE 100ConnectiveRx, a technology-enabled patient support and access solutions provider for specialty and branded medications, announced it received top rankings in independent McKinsey research, was named an MM+M Power Partner, and had three executives named to the PM360 ELITE 100. In McKinsey's market research, ConnectiveRx earned the highest affordability Net Promoter Score and was recognized as having one of the highest NPS in the patient services landscape, with over 65% of active hub programs originating from brand transitions and 95% of those brands remaining as long-term partners. These recognitions reflect the company's leadership in patient support, client service and point-of-care engagement for pharmaceutical manufacturers.FinancialContent Business PageConnectiveRx Executives Lead Industry Conversations on Access, Launch and Gross-to-Net ChallengesConnectiveRx recapped its thought leadership activities for the first half of 2026, with executives presenting at multiple industry conferences including Hub East, PAP, Asembia, and POC Now. The company debuted ShieldRx, an AI-driven pharmacy monitoring and misuse-prevention solution designed to flag suspicious activity in real time and prevent inappropriate copay fund usage. Executives also contributed to industry publications discussing topics such as gross-to-net challenges, patient access strategies, hub operations, and the impact of PBM tactics on pharmaceutical affordability programs.RxalmanacHub Services Platform Comparison (2026)This article is a comprehensive comparative analysis of four leading hub services platforms for pharmaceutical manufacturers: ConnectiveRx, AssistRx, CareMetx, and EVERSANA, evaluating their service capabilities, technology platforms, specialty pharmacy integration, and PE ownership structures. The global hub services market was valued at approximately $3.2-3.6 billion in 2024-2025, projected to grow at ~10% CAGR through 2030, with North America accounting for approximately 48% of revenue. The article serves as a strategic buying guide, recommending each platform for different buyer profiles based on manufacturer size, technology requirements, and commercial infrastructure needs.Business Wire BlogConnectiveRx and EagleForce Launch ShieldRx to Stop Pharmacy Misuse Before Claims Are PaidConnectiveRx and EagleForce announced the launch of ShieldRx, a pharmacy monitoring and misuse prevention engine that intercepts suspect pharmacy activity before claims are paid. The solution addresses the $5 billion annual manufacturer revenue loss from pharmacy misuse and invalid copay behavior by combining AI-driven risk models, real-time in-workflow risk scoring, and high-speed claim evaluation with a pharmacist resolution center. Pilot implementations across high-volume brands have demonstrated strong detection performance and ROI.PharmiWeb.comConnectiveRx and EagleForce Launch ShieldRx to Stop Pharmacy Misuse Before Claims Are PaidConnectiveRx and EagleForce jointly launched ShieldRx, a real-time pharmacy monitoring and misuse prevention solution designed to identify and block suspect activity before claims are paid. The platform addresses the $5 billion in annual manufacturer revenue loss attributed to pharmacy misuse and invalid copay behavior, combining ConnectiveRx's pharmacy workflow integration with EagleForce's real-time identity and transaction intelligence. Pilot implementations across high-volume brands have demonstrated detection performance and strong return on investment.MorningstarConnectiveRx and EagleForce Launch ShieldRx to Stop Pharmacy Misuse Before Claims Are PaidConnectiveRx and EagleForce have launched ShieldRx, a pharmacy monitoring and misuse prevention engine that identifies and stops suspect pharmacy claims before they are paid, developed to address the $5 billion annual revenue loss manufacturers face from pharmacy misuse and invalid copay behavior. The solution combines ConnectiveRx's expertise in real-time adjudication and pharmacy workflows with EagleForce's identity verification and transaction intelligence, using AI-driven risk models to evaluate claims in seconds. Pilot implementations across high-volume brands have demonstrated positive detection performance, operational readiness, and strong return on investment.PharmiWeb.comConnectiveRx Advances Clinically Integrated Provider Engagement NetworkConnectiveRx announced the scale and capabilities of its clinically integrated provider engagement network, which reaches more than 1.2 million healthcare providers across health system EHRs, outpatient, and specialty settings. The network generates physician-level data tied to actual prescribing activity and delivers in-workflow messaging campaigns to pharmaceutical manufacturer and agency partners, which the company states increases first-fill rates and adherence to therapy. This announcement highlights the company's existing platform capabilities and partnership value proposition rather than reporting a new product launch, contract win, or strategic shift.Business Wire BlogConnectiveRx Earns Top Rankings From McKinsey, Named MM+M Power Partner; Three Leaders Named to PM360 ELITE 100ConnectiveRx, a provider of technology-enabled patient support and access solutions for specialty and branded medications, received multiple industry recognitions including top rankings in independent McKinsey & Company research, where it earned the highest affordability Net Promoter Score (NPS) among patient services providers. The company was also named an MM+M Power Partner as part of the publication's 2026 Agency 100 program and had three executives recognized in the PM360 ELITE 100. These recognitions highlight ConnectiveRx's leadership in hub services, point-of-care solutions, and EHR workflow integration for pharmaceutical manufacturers.Business Wire BlogConnectiveRx Thought Leaders Steer Industry Dialogue Across Two Major Access and Patient Support ConferencesConnectiveRx showcased its expertise in patient support and access at two major industry conferences where experts discussed AI applications, market access strategies, and regulatory changes. Key figures from the company led sessions on policy outlooks and innovative support models, emphasizing rapid adoption and future-proofing of patient services.PharmiWeb.comConnectiveRx Thought Leaders Steer Industry Dialogue Across Two Major Access and Patient Support ConferencesConnectiveRx, a provider of technology-enabled patient support and access solutions for specialty and branded medications, showcased its expertise through thought leadership roles at two major industry conferences—the Copay, Reimbursement and Access Congress and the Patient Support Services Congress. Company executives including Chris Dowd, Ticia Cawley, Simon Kasmir, Kristine McGaughey, and Steve Randall led sessions on AI applications in patient support, gross-to-net management strategies, accumulators and maximizers, and hub services. Two executives—Steve Randall and Kristine McGaughey—were recently recognized on PM360's ELITE 100 list for their contributions to the pharmaceutical industry.